These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24528676)

  • 1. Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.
    Chen Z; Forman LW; Williams RM; Faller DV
    BMC Cancer; 2014 Feb; 14():90. PubMed ID: 24528676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy.
    Berardi DE; Flumian C; Rodriguez CE; Bessone MI; Cirigliano SM; Joffé ED; Fiszman GL; Urtreger AJ; Todaro LB
    J Cell Biochem; 2016 Mar; 117(3):730-40. PubMed ID: 26335446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.
    Chen Z; Forman LW; Miller KA; English B; Takashima A; Bohacek RA; Williams RM; Faller DV
    Endocr Relat Cancer; 2011 Dec; 18(6):759-71. PubMed ID: 21990324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C delta is required for survival of cells expressing activated p21RAS.
    Xia S; Forman LW; Faller DV
    J Biol Chem; 2007 May; 282(18):13199-210. PubMed ID: 17350960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation.
    Takashima A; English B; Chen Z; Cao J; Cui R; Williams RM; Faller DV
    ACS Chem Biol; 2014 Apr; 9(4):1003-14. PubMed ID: 24506253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.
    Bian Y; Teper Y; Mathews Griner LA; Aiken TJ; Shukla V; Guha R; Shinn P; Xin HW; Pflicke H; Powers AS; Li D; Jiang JK; Patel P; Rogers SA; Aubé J; Ferrer M; Thomas CJ; Rudloff U
    Mol Cancer Ther; 2019 Nov; 18(11):2097-2110. PubMed ID: 31395684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.
    Symonds JM; Ohm AM; Carter CJ; Heasley LE; Boyle TA; Franklin WA; Reyland ME
    Cancer Res; 2011 Mar; 71(6):2087-97. PubMed ID: 21335545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
    He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
    Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.
    Reyland ME; Jones DN
    Pharmacol Ther; 2016 Sep; 165():1-13. PubMed ID: 27179744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C delta negatively modulates canonical Wnt pathway and cell proliferation in colon tumor cell lines.
    Hernández-Maqueda JG; Luna-Ulloa LB; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    PLoS One; 2013; 8(3):e58540. PubMed ID: 23520519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
    Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
    Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells.
    Zhang H; Okamoto M; Panzhinskiy E; Zawada WM; Das M
    Am J Physiol Cell Physiol; 2014 Apr; 306(7):C648-58. PubMed ID: 24500281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ.
    Yuan Y; Yangmei Z; Rongrong S; Xiaowu L; Youwei Z; Sun S
    Biomed Pharmacother; 2019 Sep; 117():109165. PubMed ID: 31261030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
    Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
    BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.
    Cheng J; Tian L; Ma J; Gong Y; Zhang Z; Chen Z; Xu B; Xiong H; Li C; Huang Q
    Mol Oncol; 2015 Jan; 9(1):105-14. PubMed ID: 25156550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.
    Sette G; Salvati V; Memeo L; Fecchi K; Colarossi C; Di Matteo P; Signore M; Biffoni M; D'Andrea V; De Antoni E; Canzonieri V; De Maria R; Eramo A
    PLoS One; 2012; 7(10):e46891. PubMed ID: 23056514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Yamada K; Oikawa T; Kizawa R; Motohashi S; Yoshida S; Kumamoto T; Saeki C; Nakagawa C; Shimoyama Y; Aoki K; Tachibana T; Saruta M; Ono M; Yoshida K
    Cancer Res; 2021 Jan; 81(2):414-425. PubMed ID: 33318039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C delta enhances proliferation and survival of murine mammary cells.
    Grossoni VC; Falbo KB; Kazanietz MG; de Kier Joffé ED; Urtreger AJ
    Mol Carcinog; 2007 May; 46(5):381-90. PubMed ID: 17219421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
    Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
    Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.